Alamar Biosciences ALMR
Valuation
Multiples measured against the stock's own five-year history
Near the top of its 5-year range · 97th percentile, 5-year average -40.2x
Above its usual level · 77th percentile, 5-year average -1.9x
#4723 of 5330 stocks by PB (1 = cheapest)
Below its usual level · 28th percentile, 5-year average 19.8x
#4713 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 7.05 | – | -1.85 | 77% (pricier than usual) | #4723 of 5330 (1 = cheapest) |
| PE | -26.77 | -29.87 | -40.19 | 97% (pricier than usual) | – |
| PS | 18.77 | 13.82 | 19.80 | 28% (cheaper than usual) | #4713 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on ALMR.
Sign in to join the discussion.